population health

Research in Review

SBRT Deemed Safe and Effective in Older Patients With Lung Cancer

07/19/2017

JCP Editors

Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...

...

07/19/2017

Journal of Clinical Pathways

Research in Review

Biomarker Screening Pathway Aids Diagnosis of Monogenic Diabetes

07/18/2017

JCP Editors

A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients, according to results of a population-based assessment published in Diabetes...

A...

07/18/2017

Journal of Clinical Pathways

Research in Review

Can Active Surveillance Benefit Younger Patients With Prostate Cancer?

06/19/2017

JCP Editors

Research suggests that age can impact the risk of disease progression in low-risk prostate cancer managed with active surveillance, published in the Journal of Clinical Oncology (June 2017;35[17]:1898-1904). Recent...

...

06/19/2017

Journal of Clinical Pathways

Research in Review

ASCT Deemed Safe and Effective for Older Patients With B-Cell Malignancies

05/25/2017

JCP Editors

Older patients with B-cell malignancies benefit from progression-free survival (PFS) and overall survival (OS) improvements after autologous stem cell transplantation (ASCT), according to research that will be...

Older...

05/25/2017

Journal of Clinical Pathways

Research in Review

Young Patients With Colorectal Cancer May Benefit From More Treatment Options

05/25/2017

JCP Editors

Patients aged 45 years or younger with colorectal cancer may have better treatment options available to them because of more mutations in their tumors than older patients, according to research that will be presented...

...

05/25/2017

Journal of Clinical Pathways

Research in Review

Older Patients With CLL Have Higher Risk of Disease-Related Mortality

05/04/2017

JCP Editors

Chronic lymphocytic leukemia (CLL)-related mortality is significantly higher in patients aged 75 years or older, prompting a need for novel treatment options, according to a study published in BMC Cancer...

...

05/04/2017

Journal of Clinical Pathways

Research in Review

Testing for PD-L1 Expression to Determine Lung Cancer Treatment

11/17/2016

JCP Editors

Using PD-L1 expression to determine non-small cell lung cancer (NSCLC) treatment is becoming standard of care, according to a presentation given at the 11th Annual New York Lung Cancer Symposium (November 12,...

Using...

11/17/2016

Journal of Clinical Pathways

Department

Cognitive Factors Linked to Treatment Adherence in Elderly Patients With Cancer

10/07/2016

JCP Editors

Cognitive factors such as working memory dysfunction and depression may be predictors of non-adherence in patients with cancer, especially among the elderly, according to a study presented at the European Society for...

...

10/07/2016

Journal of Clinical Pathways

Research in Review

Fewer Incidences of Cervical Intraepithelial Neoplasia With HPV Vaccine

10/05/2016

JCP Editors

In a study published in JAMA Oncology, researchers a found that, after adjusting for changes in screening, there was a decrease in all-grade cervical intraepithelial neoplasia (CIN), a known link to cervical cancer,...

In a...

10/05/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Population Health Delivery Through Health Systems and Pharma

09/06/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

As health systems become more prevalent, they are having increasing levels of control over treatment decisions, in coordination with physicians and managed care organizations. As a result of this increased level of...

As...

09/06/2016

Journal of Clinical Pathways